Vegzelma
Payments companies reported to CMS as associated with Vegzelma. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vegzelma, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vegzelma
These are the largest totals companies reported as associated with Vegzelma. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sanjaykumar Hapani | Edmond, OK | Hematology & Oncology | $3,494.67 |
| Reezwana Chowdhury | Bethesda, MD | Gastroenterology (Internal Medicine) | $821.75 |
| Alexander Lee | Winston Salem, NC | Physician Assistant | $600.00 |
| Zachary Borman | Chevy Chase, MD | Gastroenterology (Internal Medicine) | $597.29 |
| Aja Mccutchen | Winder, GA | Gastroenterology (Internal Medicine) | $538.92 |
| Michael Schopis | New York, NY | Gastroenterology (Internal Medicine) | $532.03 |
| Nilesh Lodhia | Charlotte, NC | Gastroenterology (Internal Medicine) | $524.46 |
| Dorothy Cheng | Round Rock, TX | Nurse Practitioner | $522.20 |
| Divya Mallam | Downey, CA | Gastroenterology (Internal Medicine) | $489.83 |
| Bincy Abraham | Houston, TX | Gastroenterology (Internal Medicine) | $470.89 |
Prescribed Vegzelma?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.